Asia Pacific Nutrigenomics Market 2021-2031 by Offering, Test Technology, Test Sample, Application, End User, and Country: Trend Forecast and Growth Opportunity

Asia Pacific nutrigenomics market will grow by 16.9% annually with a total addressable market cap of $4,313.0 million over 2022-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes.

Highlighted with 32 tables and 58 figures, this 121-page report “Asia Pacific Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter’s Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Country.

Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Products
Probiotics
Prebiotics
Vitamins & Supplements
Testing Services
Nutrigenomics Clinical Testing
Nutrigenomics Research Testing

Based on Test Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Next-generation Sequencing
Real-time PCR
DNA Microarray
Sanger Sequencing

By Test Sample, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Buccal Swab Sample
Saliva Sample
Blood Sample
Other Samples

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Women’s Health
Metabolic Disorders
Immune Health
Cancer Research
Cardiovascular Diseases
Diabetes
Other Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Hospitals
Nutrition Clinics
Diagnostics Laboratories
Other End Users

Geographically, the following national/local markets are fully investigated:

Japan
China
South Korea
Australia
India
Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering，Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players

BASF SE
BioGaia
Cell Logic
Cura Integrative Medicine
DNAfit
DuPont de Nemours, Inc.
Garden of Life, LLC
GeneOmbio
Genova Diagnostics, Inc.
GX Sciences, Inc.
Ingredion Incorporated
Jarrow Formulas Inc.
Koninklijke DSM N.V.
MedGenome
Metagenics, Inc.
Nutrigenomix Inc.
Unilever Group
XCODE Life
Yakult Honsha Co., Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Frequently Asked Questions about the Asian Pacific Nutrigenomics Market

What is the estimated value of the Asian Pacific Nutrigenomics Market?

The Asian Pacific Nutrigenomics Market was estimated to be valued at $166 Million in 2021.

What is the growth rate of the Asian Pacific Nutrigenomics Market?

The growth rate of the Asian Pacific Nutrigenomics Market is 16.9%, with an estimated value of $791 Million by 2031.

What is the forecasted size of the Asian Pacific Nutrigenomics Market?

The Asian Pacific Nutrigenomics Market is estimated to be worth $791 Million by 2031.

Who are the key companies in the Asian Pacific Nutrigenomics Market?

Key companies in the Asian Pacific Nutrigenomics Market include BASF SE, BioGaia, Cell Logic, Cura Integrative Medicine, DNAfit, DuPont de Nemours, Inc., Garden of Life, LLC, GeneOmbio, Genova Diagnostics, Inc. and GX Sciences, Inc..

Report Attribute	Details
No. of Pages	121
Published	June 2022
Forecast Period	2021 - 2031
Estimated Market Value ( USD ) in 2021	$ 166 Million
Forecasted Market Value ( USD ) by 2031	$ 791 Million
Compound Annual Growth Rate	16.9%
Regions Covered	Asia Pacific

1 Introduction

1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics

2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 Segmentation of Asia Pacific Market by Offering

3.1 Market Overview by Offering
3.2 Products
3.3.1 Probiotics
3.3.2 Prebiotics
3.3.3 Vitamins & Supplements
3.3 Testing Services
3.3.1 Nutrigenomics Clinical Testing
3.3.2 Nutrigenomics Research Testing

4 Segmentation of Asia Pacific Market by Test Technology

4.1 Market Overview by Test Technology
4.2 Next-generation Sequencing
4.3 Real-time PCR
4.4 DNA Microarray
4.5 Sanger Sequencing

5 Segmentation of Asia Pacific Market by Test Sample

5.1 Market Overview by Test Sample
5.2 Buccal Swab Sample
5.3 Saliva Sample
5.4 Blood Sample
5.5 Other Samples

6 Segmentation of Asia Pacific Market by Application

6.1 Market Overview by Application
6.2 Women’s Health
6.3 Metabolic Disorders
6.4 Immune Health
6.5 Cancer Research
6.6 Cardiovascular Diseases
6.7 Diabetes
6.8 Other Applications

7 Segmentation of Asia Pacific Market by End User

7.1 Market Overview by End User
7.2 Hospitals
7.3 Nutrition Clinics
7.4 Diagnostics Laboratories
7.5 Other End Users

8 Asia-Pacific Market 2021-2031 by Country

8.1 Overview of Asia-Pacific Market
8.2 Japan
8.3 China
8.4 Australia
8.5 India
8.6 South Korea
8.7 Rest of APAC Region

9 Competitive Landscape

9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles

BASF SE
BioGaia
Cell Logic
Cura Integrative Medicine
DNAfit
DuPont de Nemours, Inc.
Garden of Life, LLC
GeneOmbio
Genova Diagnostics, Inc.
GX Sciences, Inc.
Ingredion Incorporated
Jarrow Formulas Inc.
Koninklijke DSM N.V.
MedGenome
Metagenics, Inc.
Nutrigenomix Inc.
Unilever Group
XCODE Life
Yakult Honsha Co., Ltd.

List of Tables

Table 1. Snapshot of Asia Pacific Nutrigenomics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in Asia Pacific Nutrigenomics Market
Table 6. Asia Pacific Nutrigenomics Market by Offering, 2021-2031, $ mn
Table 7. Asia Pacific Nutrigenomics Market: Products by Type, 2021-2031, $ mn
Table 8. Asia Pacific Nutrigenomics Market: Testing Services by Type, 2021-2031, $ mn
Table 9. Asia Pacific Nutrigenomics Market by Test Technology, 2021-2031, $ mn
Table 10. Asia Pacific Nutrigenomics Market by Test Sample, 2021-2031, $ mn
Table 11. Asia Pacific Nutrigenomics Market by Application, 2021-2031, $ mn
Table 12. Asia Pacific Nutrigenomics Market by End User, 2021-2031, $ mn
Table 13. APAC Nutrigenomics Market by Country, 2021-2031, $ mn
Table 14. Japan Nutrigenomics Market by Offering, 2021-2031, $ mn
Table 15. Japan Nutrigenomics Market by Application, 2021-2031, $ mn
Table 16. Japan Nutrigenomics Market by End User, 2021-2031, $ mn
Table 17. China Nutrigenomics Market by Offering, 2021-2031, $ mn
Table 18. China Nutrigenomics Market by Application, 2021-2031, $ mn
Table 19. China Nutrigenomics Market by End User, 2021-2031, $ mn
Table 20. Australia Nutrigenomics Market by Offering, 2021-2031, $ mn
Table 21. Australia Nutrigenomics Market by Application, 2021-2031, $ mn
Table 22. Australia Nutrigenomics Market by End User, 2021-2031, $ mn
Table 23. India Nutrigenomics Market by Offering, 2021-2031, $ mn
Table 24. India Nutrigenomics Market by Application, 2021-2031, $ mn
Table 25. India Nutrigenomics Market by End User, 2021-2031, $ mn
Table 26. South Korea Nutrigenomics Market by Offering, 2021-2031, $ mn
Table 27. South Korea Nutrigenomics Market by Application, 2021-2031, $ mn
Table 28. South Korea Nutrigenomics Market by End User, 2021-2031, $ mn
Table 29. Nutrigenomics Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 30. BASF SE: Company Snapshot
Table 31. BASF SE: Business Segmentation
Table 32. BASF SE: Product Portfolio

List of Figures

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Asia Pacific Nutrigenomics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Nutrigenomics Market
Figure 7. Number of Overweight/Obese People and Diabetic Population in the World, 1980, 2020, and 2045F, in million
Figure 8. Leading Causes of Death in the World, 2019-2020, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Asia Pacific Nutrigenomics Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of Asia Pacific Nutrigenomics Market
Figure 14. Breakdown of Asia Pacific Nutrigenomics Market by Offering, 2021-2031, % of Revenue
Figure 15. Asia Pacific Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)
Figure 16. Asia Pacific Nutrigenomics Market by Offering: Products, 2021-2031, $ mn
Figure 17. Asia Pacific Nutrigenomics Market by Products: Probiotics, 2021-2031, $ mn
Figure 18. Asia Pacific Nutrigenomics Market by Products: Prebiotics, 2021-2031, $ mn
Figure 19. Asia Pacific Nutrigenomics Market by Products: Vitamins & Supplements, 2021-2031, $ mn
Figure 20. Asia Pacific Nutrigenomics Market by Offering: Testing Services, 2021-2031, $ mn
Figure 21. Asia Pacific Nutrigenomics Market by Testing Services: Nutrigenomics Clinical Testing, 2021-2031, $ mn
Figure 22. Asia Pacific Nutrigenomics Market by Testing Services: Nutrigenomics Research Testing, 2021-2031, $ mn
Figure 23. Breakdown of Asia Pacific Nutrigenomics Market by Test Technology, 2021-2031, % of Sales Revenue
Figure 24. Asia Pacific Addressable Market Cap in 2022-2031 by Test Technology, Value ($ mn) and Share (%)
Figure 25. Asia Pacific Nutrigenomics Market by Test Technology: Next-generation Sequencing, 2021-2031, $ mn
Figure 26. Asia Pacific Nutrigenomics Market by Test Technology: Real-time PCR, 2021-2031, $ mn
Figure 27. Asia Pacific Nutrigenomics Market by Test Technology: DNA Microarray, 2021-2031, $ mn
Figure 28. Asia Pacific Nutrigenomics Market by Test Technology: Sanger Sequencing, 2021-2031, $ mn
Figure 29. Breakdown of Asia Pacific Nutrigenomics Market by Test Sample, 2021-2031, % of Sales Revenue
Figure 30. Asia Pacific Addressable Market Cap in 2022-2031 by Test Sample, Value ($ mn) and Share (%)
Figure 31. Asia Pacific Nutrigenomics Market by Test Sample: Buccal Swab Sample, 2021-2031, $ mn
Figure 32. Asia Pacific Nutrigenomics Market by Test Sample: Saliva Sample, 2021-2031, $ mn
Figure 33. Asia Pacific Nutrigenomics Market by Test Sample: Blood Sample, 2021-2031, $ mn
Figure 34. Asia Pacific Nutrigenomics Market by Test Sample: Other Samples, 2021-2031, $ mn
Figure 35. Breakdown of Asia Pacific Nutrigenomics Market by Application, 2021-2031, % of Revenue
Figure 36. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 37. Asia Pacific Nutrigenomics Market by Application: Women’s Health, 2021-2031, $ mn
Figure 38. Asia Pacific Nutrigenomics Market by Application: Metabolic Disorders, 2021-2031, $ mn
Figure 39. Asia Pacific Nutrigenomics Market by Application: Immune Health, 2021-2031, $ mn
Figure 40. Asia Pacific Nutrigenomics Market by Application: Cancer Research, 2021-2031, $ mn
Figure 41. Asia Pacific Nutrigenomics Market by Application: Cardiovascular Diseases, 2021-2031, $ mn
Figure 42. Asia Pacific Nutrigenomics Market by Application: Diabetes, 2021-2031, $ mn
Figure 43. Asia Pacific Nutrigenomics Market by Application: Other Applications, 2021-2031, $ mn
Figure 44. Breakdown of Asia Pacific Nutrigenomics Market by End User, 2021-2031, % of Revenue
Figure 45. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 46. Asia Pacific Nutrigenomics Market by End User: Hospitals, 2021-2031, $ mn
Figure 47. Asia Pacific Nutrigenomics Market by End User: Nutrition Clinics, 2021-2031, $ mn
Figure 48. Asia Pacific Nutrigenomics Market by End User: Diagnostics Laboratories, 2021-2031, $ mn
Figure 49. Asia Pacific Nutrigenomics Market by End User: Other End Users, 2021-2031, $ mn
Figure 50. Breakdown of APAC Nutrigenomics Market by Country, 2021 and 2031, % of Revenue
Figure 51. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 52. Nutrigenomics Market in Japan, 2021-2031, $ mn
Figure 53. Nutrigenomics Market in China, 2021-2031, $ mn
Figure 54. Nutrigenomics Market in Australia, 2021-2031, $ mn
Figure 55. Nutrigenomics Market in India, 2021-2031, $ mn
Figure 56. Nutrigenomics Market in South Korea, 2021-2031, $ mn
Figure 57. Nutrigenomics Market in Rest of APAC, 2021-2031, $ mn
Figure 58. Growth Stage of Asia Pacific Nutrigenomics Industry over the Forecast Period

Companies Mentioned

A selection of companies mentioned in this report includes:

BASF SE
BioGaia
Cell Logic
Cura Integrative Medicine
DNAfit
DuPont de Nemours, Inc.
Garden of Life, LLC
GeneOmbio
Genova Diagnostics, Inc.
GX Sciences, Inc.
Ingredion Incorporated
Jarrow Formulas Inc.
Koninklijke DSM N.V.
MedGenome
Metagenics, Inc.
Nutrigenomix Inc.
Unilever Group
XCODE Life
Yakult Honsha Co., Ltd.

Methodology

LOADING...

In-depth qualitative analyses include identification and investigation of the following aspects:

Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Based on Test Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

By Test Sample, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Geographically, the following national/local markets are fully investigated:

Selected Key Players

What is the estimated value of the Asian Pacific Nutrigenomics Market?

What is the growth rate of the Asian Pacific Nutrigenomics Market?

What is the forecasted size of the Asian Pacific Nutrigenomics Market?

Who are the key companies in the Asian Pacific Nutrigenomics Market?

Table of Contents

Companies Mentioned

Methodology

Related Topics

Related Reports

Nutrigenomics Market by Type of Sample, Type of Sample Collection Method and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

Genomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Global Nutrigenomics Testing Market Forecast to 2027

Nutrigenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Global Nutrigenomics Market (2023-2028) by Product, Applications, and Geography, Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession with Ansoff Analysis